SILVER POINT CAPITAL L.P. purchased 5.3% of their position (250K shares) of KEENOVA THERAPEUTICS PLC on the open market
Open‑market purchase worth $23.06M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/9/2026ACC: 0001193125-26-009126
10% Owner
Since Nov 2025
+250K
Net shares
Net buyer
$23.06M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
250K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+250K
Price / share
$92.25
Trade value
$23.06M
% of position
5.3%
1/7/2026
4.70M→4.95M
Total
Net shares
+250K
Net value
$23.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2026 | P · Purchase | +250K | $92.25 | $23.06M | 5.3% | 4.70M | 4.95M |
| Total | +250K | $23.06M | ||||||
Derivative Transactions0
No derivative transactions reported